Effects of autogenic training on nitroglycerin-induced headaches

Headache

Volumn 47, Issue 3, 2007, Pages 371-383

  Juhasz, Gabriella ^a,b   Zsombok, Terezia ^b   Gonda, Xenia ^b   Nagyne, Nora ^b   Modosne, Edit ^b   Bagdy, Gyorgy ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Autogenic training; Cortisol; Headache; Migraine; Nitroglycerin

Indexed keywords

GLYCERYL TRINITRATE; HYDROCORTISONE;

ACUTE DISEASE; ADULT; ARTICLE; AUTOGENIC TRAINING; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED HEADACHE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INCIDENCE; LONG TERM CARE; MEDICAL DOCUMENTATION; MIGRAINE; MIGRAINE AURA; PRIORITY JOURNAL; PROPHYLAXIS; PROVOCATION TEST; PULSE RATE; STANDARD; STATISTICAL SIGNIFICANCE; STRESS; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, SUBLINGUAL; ADULT; AUTOGENIC TRAINING; FEMALE; HEADACHE; HUMANS; MIDDLE AGED; NITROGLYCERIN; TREATMENT OUTCOME;

EID: 33947229348     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00718.x     Document Type: Article

References (43)

1. Zsombok T, Juhasz G, Budavari A,Vitrai J, Bagdy G. Effect of autogenic training on drug consumption in patients with primary headache: An 8-month follow-up study. Headache. 2003;43:251-257.
2. Bigal ME, Lipton RB, Krymchantowski AV. The medical management of migraine. Am J Ther. 2004;11:130-140.
3. Bagdy G, Zsombok T, Gonda X, Juhasz G. Autogenic training might help headache patients. Focus Alternative Compl Ther (FACT). 2003;8:345-347.
4. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004;110:675-680.
5. Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia. 2004;24:110-119.
6. Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders. Endocr Rev. 2001;22:502-548.
7. Gordon ML, Lipton RB, Brown SL, van Praag HM. The neuroendocrine challenge paradigm in headache research. Cephalalgia. 1995;15:292-296.
8. Pawlow LA, Jones GE. The impact of abbreviated progressive muscle relaxation on salivary cortisol and salivary immunoglobulin A (sIgA). Appl Psychophysiol Biofeedback. 2005;30:375-387.
9. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia. 2004;24(suppl 1):9-160.
10. American. Psychiatric Association. Diagnostic and Statistical Manual-IV. Washington, D.C., and London, England: American Psychiatric Press, Inc.; 1994.
11. Attanasio V, Andrasik F, Blanchard EB. Cognitive therapy and relaxation training in muscle contraction headache: Efficacy and cost-effectiveness. Headache. 1987;27:254-260.
12. Murphy AI, Lehrer PM, Jurish S. Cognitive coping skills training and relaxation training as treatments for tension headaches. Behavior Therapy. 1990;21:89-98.
13. Spielberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1970.
14. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
15. Bagdy G, Arato M. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects. Psychopharmacology (Berl). 1998;136:342-348.
16. Sipos K, Sipos M. The development and validation of the Hungarian form of the State-Trait Anxiety Inventory. In: Spielberger CD, Diaz-Guerrero R, eds. Cross-cultural Anxiety. Washington: Hemisphere; 1983;27-39.
17. Simon A. A Zung-féle depresszió-skála (The Zung Self-rating Depression Scale). In: Mérei F, Szakács F, eds. Pszichodiagnosztikai Vademecum, Nemzeti Tankönyvkiadó, Budapest; 1998:180-185.
18. Penzien DB, Rains JC, Andrasik F. Behavioral management of recurrent headache: Three decades of experience and empiricism. Appl Psychophysiol Biofeedback. 2002;27:163-181.
19. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106:461-470.
20. Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005;128:932-939.
21. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport. 2000;11:3071-3075.
22. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20:907-918.
23. Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241-247.
24. Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia. 2005;25:179-183.
25. Tvedskov JF, Thomsen LL, Thomsen LL, et al. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Cephalalgia. 2004;24:1076-1087.
26. Leone M, Attanasio A, Croci D, et al. The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study. Neurology. 2000;55:136-139.
27. Bagdy G, Calogero AE, Murphy DL, Szemeredi K. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology. 1989;125:2664-2669.
28. Bagdy G. Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. Ann N Y Acad Sci. 1998;851:357-363.
29. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol. 2001;4:399-408.
30. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res. 1996;73:277-280.
31. Calogero AE, Bagdy G, Moncada ML, D'Agata R. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol. 1993;136:381-387.
32. Bagdy G, Calogero AE, Aulakh CS, Szemeredi K, Murphy DL. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. Neuroendocrinology. 1989;50:241-247.
33. Murphy DL, Zohar J, Lawlor BA, et al. Hormonal responses to serotonergic drugs as a means to evaluate brain serotonergic function in humans. In: Paoletti R, Vanhoute PM, eds. Serotonin: From Cell Biology to Pharmacology and Therapeutics. The Netherlands: Kluwer Academic Publishers; 1990;565-580.
34. Stetter F, Kupper S. Autogenic training: A meta-analysis of clinical outcome studies. Appl Psychophysiol Biofeedback. 2002;27:45-98.
35. Loder E, Biondi D. Disease modification in migraine: A concept that has come of age? Headache. 2003;43:135-143.
36. Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain. 2004;127:220-230.
37. Mohr C, Binkofski F, Erdmann C, Buchel C, Helmchen C.The anterior cingulate cortex contains distinct areas dissociating external from self-administered painful stimulation: A parametric fMRI study. Pain. 2005;114:347-357.
38. Porro CA, Lui F, Facchin P, Maieron M, Baraldi P. Percept-related activity in the human somatosensory system: Functional magnetic resonance imaging studies. Magn Reson Imaging. 2004;22:1539-1548.
39. Lopez-Avila A, Coffeen U, Ortega-Legaspi JM, del Angel R, Pellicer F. Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain. 2004;111:136-143.
40. De Tommaso M, Murasecco D, Libro G, et al. Modulation of trigeminal reflex excitability in migraine: Effects of attention and habituation on the blink reflex. Int J Psychophysiol. 2002;44:239-249.
41. Afra J, Proietti CA, Sandor PS, Schoenen J. Comparison of visual and auditory evoked cortical potentials in migraine patients between attacks. Clin Neurophysiol. 2000;111:1124-1129.
42. Afra J, Cecchini AP, De PV, Albert A, Schoenen J. Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain. 1998;121:233-241.
43. Mulder EJ, Linssen WH, de Geus EI. Reduced sensory anticipation in migraine. Psychophysiology. 2002;39:166-174.